Navigation Links
Dr. Charles Kennedy, Vice President of Health Information Technology for WellPoint, Inc., to Present Today at The 4th Annual World Healthcare Innovation and Technology Congress (WHIT v.4.0)
Date:12/9/2008

WASHINGTON, Dec. 9 /PRNewswire-FirstCall/ -- Charles D. Kennedy, MD, Vice President of Health Information Technology for WellPoint, Inc. (NYSE: WLP) will present today at The 4th Annual World Healthcare Innovation and Technology Congress (WHIT v.4.0), which is expected to convene with over 400 health care executives to discuss the next generation of healthcare innovation and technology.

Dr. Kennedy's presentation, entitled "E-Prescribing: An Early Health Information Exchange Tool," will discuss how e-Prescribing offers a path to help reduce the underlying cost of care, improve quality and safety, and reduce administrative costs by helping physicians, patients, and all care givers make better decisions using evidence based medicine. Dr. Kennedy, as a member of the keynote reactor panel, will also be part of the keynote session focused on the importance of partnering with the consumer for better health by providing the health plan industry's perspective.

At WellPoint, Dr. Kennedy is responsible for building technical solutions which leverage health plan data sets to help improve patient care. With over 20 years of healthcare experience, Dr. Kennedy has deployed several advanced health IT tools and was responsible for helping with strategic acquisitions and investments in companies that focus on healthcare technology.

In addition to being a recognized expert in Health IT, Dr. Kennedy has served on multiple boards such as the National Alliance for Health Information Technology (NAHIT), the California Regional Health Information Organization (CalRHIO), AHIC Successor, Inc., and was a founding commissioner of the Certification Commission for Health Information Technology (CCHIT).

For more information about The 4th Annual World Healthcare Innovation and Technology Congress (WHIT v.4.0), please visit
'/>"/>

SOURCE WellPoint, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Charleston, S.C., Market Integration Likely to Drive Physician Groups to Seek Health System Affiliation
2. College of American Pathologists Selects Charles Roussel as Its New Executive Vice President
3. Foundation Radiology Group Announces Multi-Year Deal with Charles Cole Memorial Hospital
4. The Hope Clinic in Charleston, SC invests in technology to prevent vision loss in patients
5. [video] Charles Fust, CEO of SinoFresh HealthCare, Inc. Discusses Preliminary Test Results From In Vivo Pilot Study on WallSt.nets 3-Minute Press Show
6. WXYZ-TV/Channel 7 is On Your Side With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History
7. Peter Ell receives SNMs Georg Charles de Hevesy Nuclear Pioneer Award
8. Advertising Hall of Famer Charles D. Peebler Receives Honor for Work Supporting Cure for Progressive Supernuclear Palsy
9. Charles D. McCrary Joins Southern Research Institute Board of Directors
10. The California Dental Association Foundation Presents Inaugural Humanitarian Award to USC Mobile Dental Clinics Champion Charles M. Goldstein, DDS, MPH
11. Doug Flutie, Jr. Foundation Grants NAA $10,000 for Burbacher/Charleston Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...aused by the build-up of a brain peptide called am... been the focus of almost all drug research pursui...ndition. , But that may be counterproductive, sa...tment of Physiology and Pharmacology, Sackler Facu...that amyloid-beta is also necessary to maintain pr...
(Date:11/23/2009)...Life-Science Focused Strategic Communications Agen...cation Professionals , Sa... a life science-focused strategic communications a...09 MarCom Gold Award in the design/website homepag...ion of Marketing and Communication Professionals. ...
(Date:11/23/2009)...PRNewswire-FirstCall/--InstacareCorp.(OTCBulletinB... MD@Hand ,target=,_blank,title=, MD@Hand ,> MD@Han...,title=, MD@Hand ,> MD@Hand ,> MD@Hand ,target=,_...,title=, MD@Hand ,target=,_blank,title=, MD@Hand ,...=,_blank,title=, MD@Hand ,> MD@Hand ,> MD@Hand ,t...
(Date:11/23/2009)...reditationforFivePopulationHealthPrograms ,, L...ulationHealthImpactInstitute(PHII),anon-profit501(...ardofDirectorshasapprovedtheHealthcareTransparency...fdevelopment.Nurtur(TM),alife,health,andwellnessco...eceivetheH-TAPaccreditationsealforfiveofitsprogram...
(Date:11/23/2009)....23/PRNewswire/--ChristineHoehnehasjoined LocktonB...ncebrokerage.HoehnewillserveasanAccountExecutivein...ockton,s Minneapolis office. ,, (Logo: http://w... ,, "WearethrilledtohaveChristinejoinourteam,"s...tServices."Shebroadensourabilitytoassistourmultina...
Breaking Medicine News(10 mins):Health News:Upending textbook science on Alzheimer's disease 2Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 2Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 3Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 2Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 3Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 4Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 5Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 6Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 7Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 2Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 3Health News:Lockton Benefit Group Expands International Benefit Team 2
... of a chemotherapeutic drug for leukemia to a stan...rs to enhance the response of certain ovarian canc...y led by researchers in the Duke Comprehensive Can...d Deanna Teoh, M.D., a fellow in gynecologic oncol...
... help older adults stay sharp , , SUNDAY, ...(at least in a video game) is just one of many way...in memory. , In this case, a study found that old... the world, according to the American Geriatric So...
...recently released study led by Joseph A. Roscoe, P...the American Cancer Society and the National Cance...stbands are effective in reducing nausea associate... This all natural and easy to administer remedy is...
...therford Hospital, Inc., a QHR management client s...anagement client since 1994, were recently ranked ...n overall organizational performance by Thomson Re...entwood, Tenn. (PRWEB) April 18, 2009 -- Rutherfor...
... may lead to better detection and treatment , ...tive receptor found in certain pancreatic cancers ...disease. , A third of human pancreatic cancers l...tudies had noted as being active in some lung canc...
...rgy Awareness Month , , SATURDAY, April 18...e offered at more than 200 sites across the United...gy Awareness Month. , Adults and children with sym...any people don,t realize their breathing problem m...
Other Medicine News:Health News:Addition of dasatinib to standard chemo cocktail may enhance effect in certain ovarian cancers 2Health News:Relief Is Available for Cancer Patients Suffering from Radiation Therapy-Related Nausea 2Health News:Two QHR Management Clients Named to Thomson Reuters' 100 Top Hospitals Rutherford Hospital, Inc. and Wooster Community Hospital Honored for Performance Excellence 2Health News:Research Takes Aim at Pancreatic Cancer 2Health News:Group Urges Public to Take Free Asthma Tests in May 2
(Date:11/23/2009)..., EXTON,Pa.,Nov.23/PRNewswire/--BioTrendsRese...M): Feraheme report,thesecondinamulti-phasesyndi...snewIVironproduct,Feraheme,throughthefirstsixmonth...quantitativeinformationfrom50uniqueNephrologistsan...ssesstrialanduseofFeraheme,obstaclestouse,reasonst...
(Date:11/23/2009)..., WALTHAM,Mass.,Nov.23/PRNewswire/--ProteonTh...studyofitsleadproduct,PRT-201,inend-stagerenaldise...graft(AVG)creation.TheAVGstudyrepresentsProteon,ss...iouslyannouncingtheinitiationofaPhase1/2studyofPRT...sfistula(AVF)creationearlierthisyear.Proteonalsoan...
(Date:11/23/2009)..., SOUTHSANFRANCISCO,Calif.,Nov.23/PRNewswire-...cedthatDr.TedW.LoveandDr.DavidC.U,Prichardhaveagre...ionoftheproposedmergerbetweenAnesivaandArcionThera...ervotescheduledtotakeplaceatthepreviouslyannounced...ecember3,2009at9:00a.m.PSTat400OysterPoint,Suite10...
Breaking Medicine Technology:Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2Proteon Initiates Second Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Brown professor continues debate over recovered memory 50995 1Brown professor continues debate over recovered memory 50995 2Providence Service Corporation Does Not Expect California Budget Issues to Materially Impact Its Business in the State 50992 1Providence Service Corporation Does Not Expect California Budget Issues to Materially Impact Its Business in the State 50992 2Fewer Shots Could Still Protect Kids From Pneumonia 50989 1Fewer Shots Could Still Protect Kids From Pneumonia 50989 2
...-beta 2,inhibitor AP 12009, developed by Antisense... in the systemic treatment of pancreatic carcinoma...2009, administered,intravenously, showed a clear p... carcinoma, who received AP 12009 for seven days e...ad a median survival time of 29.6 weeks,(6.8 month...
... Congress in Toronto, MIAMI, June 2 Manuel R. Ca...rgery and Pathology at the University of Miami -,L...d the value of,monitoring cell- mediated immunity ...splants using a regular laboratory assay of cell f... "Immune monitoring with Cylex,ImmuKnow(R) in the ...
Other Medicine Technology:Anti-TGF-Beta Antisense AP 12009 Shows Very Good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma, Malignant Melanoma and Colorectal Carcinoma 2Anti-TGF-Beta Antisense AP 12009 Shows Very Good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma, Malignant Melanoma and Colorectal Carcinoma 3Anti-TGF-Beta Antisense AP 12009 Shows Very Good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma, Malignant Melanoma and Colorectal Carcinoma 4University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients 2University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients 3University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients 4
7.75mm diameter Corneal Trephine Blades
6.5mm diameter Corneal Trephine Blades
5.5mm diameter Corneal Trephine Blades
7.50mm Open Trephine Handle
Medicine Products: